FDA Orange Book
Is there a generic for Thyro-tabs?
Thyro-tabs contains levothyroxine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Thyro-tabs (levothyroxine).
Run it in Rivvi
Map Thyro-tabs and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Thyro-tabs products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 0.025MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.05MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.075MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.088MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.112MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.125MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.137MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.175MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
| tablet, oral | 0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Marketed (Rx) | AB1,AB2,AB3,AB4 | 0 | None |
NDA 021116, held by ALVOGEN INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Thyro-tabs NDC codes
Questions
Is there a generic for Thyro-tabs?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Thyro-tabs (levothyroxine).
What is the generic name for Thyro-tabs?
The active ingredient in Thyro-tabs is levothyroxine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.